Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019

NCT04338009 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

OTHER: Discontinuation of ARB/ACEI
OTHER: Continuation of ARB/ACEI

Sponsor

University of Pennsylvania

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]